KLP Kapitalforvaltning’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$136K Buy
6,800
+2,500
+58% +$50.2K ﹤0.01% 1922
2025
Q1
$84.6K Hold
4,300
﹤0.01% 2084
2024
Q4
$96.8K Buy
+4,300
New +$96.8K ﹤0.01% 2101